Senti Biosciences Holdings, Inc. - 8-K Filing
Senti Biosciences completes merger with ST NewCo Limited, issuing contingent value rights totaling up to $60 million based on SENTI-20 milestones. (Items: 1.01 Entry into a Material Definitive Agreement, 2.01 of this Current Report on Form 8-K and is incorporated herein by reference, 3.02 Unregistered Sales of Equity Securities, 9.01 Financial Statements and Exhibits)
Tickers: $SNTI